Pursuant to the correction that has taken place in recent weeks with respect to the shares in Tesla, further downside risk now appears limited by close and important technical support levels at 250.56 USD. Investors have an opportunity to buy the stock and target the $ 279.7.
The company usually posts poor financials for mid or long term investments.
The company has poor fundamentals for a short-term investment strategy.
Share prices are approaching a strong support area in daily data, which offers good timing for investors.
Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Over the last twelve months, the sales forecast has been frequently revised upwards.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Low profitability weakens the company.
The group shows a rather high level of debt in proportion to its EBITDA.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The company's earnings releases usually do not meet expectations.
For the past year, analysts have significantly revised downwards their profit estimates.
The underlying tendency is negative on the weekly chart below the resistance at 299.1 USD
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.